Market Outlook

By 2035, the U.S. IoT-Enabled Home Healthcare Devices Market is expected to reach approximately USD 81.08 billion, expanding at a CAGR of 15.80% during the forecast period 2026–2035. The market is estimated at USD 18.70 billion in 2025, with historical analysis covering 2021 to 2024. Values in this report are expressed in USD billions.

For the purpose of market sizing, the report covers healthcare and medical devices designed for use in residential or non-institutional settings that incorporate internet, cellular, Bluetooth, Wi-Fi, cloud-linked, near-field, or comparable digital connectivity for collection, transmission, analysis, storage, or clinician access to patient-generated health data. The scope includes connected glucose monitoring systems, blood pressure monitors, cardiac monitoring devices, pulse oximeters, respiratory and sleep devices, smart scales, connected thermometers, medication-management devices, home diagnostic systems, multiparameter monitors, wearable medical sensors, and associated connected therapeutic devices. Standalone telehealth consultations, generic wellness wearables without meaningful healthcare functionality, unrelated smart-home products, and software sold independently of a connected device are excluded.

The historical market is estimated to have expanded from approximately USD 9.65 billion in 2021 to USD 15.95 billion in 2024, supported by normalization of outpatient care after the pandemic, wider adoption of remote patient monitoring, rapid penetration of continuous glucose monitoring, growing physician familiarity with patient-generated data, and health-system investment in post-discharge monitoring programs. The market reached approximately USD 18.70 billion in 2025 as connected monitoring moved beyond pilot programs and became increasingly incorporated into diabetes, hypertension, cardiac, respiratory, sleep, post-acute, and senior-care pathways.

Growth is expected to accelerate as the home becomes a more clinically important care setting. The U.S. population aged 65 years and older has moved above 64 million, creating a large and expanding population requiring longitudinal disease management, medication support, fall-risk reduction, cardiometabolic monitoring, and post-acute surveillance. At the same time, nearly half of U.S. adults have hypertension, diabetes affects a substantial portion of the adult population, and chronic respiratory and cardiovascular diseases continue to generate repeated physician visits, hospitalizations, and emergency utilization.

The economic case for IoT-enabled home healthcare devices is consequently shifting. Buyers are no longer evaluating connected devices only as technology purchases. Health systems, physician groups, Medicare Advantage organizations, home healthcare providers, and risk-bearing care organizations increasingly evaluate whether a connected device can prevent an avoidable admission, shorten a hospital stay, reduce an in-person visit, improve medication adherence, support reimbursement capture, improve quality metrics, or allow clinical teams to manage larger patient populations without proportional increases in staffing.

On the current forecast trajectory, the market is expected to reach approximately USD 21.65 billion in 2026, USD 38.94 billion by 2030, and USD 81.08 billion by 2035. The most attractive value pools are expected to develop around continuous biosensing, connected cardiometabolic management, cellular-enabled monitoring, AI-supported alert prioritization, home diagnostic ecosystems, interoperable multiparameter devices, remote respiratory management, and technologies designed to integrate directly into provider workflow rather than operating as isolated consumer applications.

 

Introduction

According to the U.S. IoT-Enabled Home Healthcare Devices Market Report, connected home healthcare is evolving from a supplementary digital-health category into a foundational component of longitudinal care delivery. This transition reflects a structural change in where healthcare data are generated. Historically, most clinically actionable physiologic information was captured during physician visits, diagnostic testing, or hospital encounters. IoT-enabled devices increasingly allow blood glucose, blood pressure, heart rhythm, oxygen saturation, respiratory performance, weight, temperature, sleep parameters, medication use, and other measurements to be captured in the patient’s home and transmitted into professional care environments.

The market opportunity is therefore larger than the sale of individual connected devices. The competitive value of these products increasingly depends on whether the manufacturer can create a reliable chain from measurement to transmission, interpretation, escalation, documentation, and clinical action.

The U.S. is particularly attractive because of the combination of high chronic-disease prevalence, advanced broadband and smartphone adoption, strong medical-device purchasing capacity, established digital-health reimbursement mechanisms, sophisticated integrated delivery networks, a large Medicare population, mature electronic health record infrastructure, and a highly developed home healthcare industry. U.S. spending on services provided by freestanding home health agencies alone exceeded USD 169 billion in 2024, illustrating the scale of healthcare already delivered outside conventional hospitals and physician offices.

The addressable population is also expanding. Hypertension affects approximately 120 million U.S. adults, while diabetes, cardiovascular disease, chronic respiratory conditions, obesity-related complications, sleep disorders, and multimorbidity create recurring demand for monitoring between clinical encounters. For manufacturers, this transforms the home from the endpoint of a discharge pathway into a recurring device-utilization environment.

The market is not homogeneous. Continuous glucose monitoring is currently one of the most commercially advanced connected home-device categories, supported by recurring sensor consumption, strong physician familiarity, growing consumer awareness, and an expanding eligible population. Connected cardiovascular monitoring is evolving through blood pressure devices, ECG patches, handheld ECG systems, weight monitoring, wearable cardiac technologies, and remote implant follow-up. Respiratory and sleep management creates another large connected-device ecosystem through CPAP platforms, pulse oximetry, spirometry, oxygen monitoring, and therapy-adherence systems.

Procurement is also becoming more complex. Traditional medical-device purchasing was dominated by hospitals and value-analysis committees. IoT-enabled home healthcare devices may instead be selected by health systems, physician practices, specialty clinics, home healthcare agencies, RPM service companies, pharmacies, durable medical equipment distributors, Medicare Advantage plans, employers, retail channels, or patients themselves. Manufacturers therefore require channel strategies that address clinical validation, reimbursement, consumer experience, cybersecurity, data interoperability, fulfillment logistics, replacement cycles, technical support, and clinician workflow simultaneously.

From 2026 through 2035, the strategic question for clients will not simply be how many connected devices will be sold. The more important questions will concern which device categories become embedded in reimbursed care pathways, which companies control the data relationship with providers and patients, which technologies achieve sufficient adherence to generate meaningful clinical information, and which business models can produce attractive recurring economics without increasing administrative workload for physicians.

 

Key Market Drivers: What’s Fueling the U.S. IoT-Enabled Home Healthcare Devices Market Boom?

The first major driver is the scale of chronic disease requiring continuous or frequent monitoring. Hypertension affects close to half of U.S. adults, yet control rates remain inadequate. This creates a large addressable population for connected blood pressure monitors capable of transmitting longitudinal readings rather than depending on measurements obtained during occasional office visits. The commercial opportunity extends beyond selling a blood pressure cuff because longitudinal data can support medication titration, risk stratification, adherence management, and identification of patients requiring escalation.

Diabetes is another major growth engine. Connected glucose technologies have already demonstrated how a traditional measurement category can be transformed into a data-intensive recurring device model. Continuous glucose monitoring eliminates much of the episodic nature of finger-stick testing and creates continuous information on glucose patterns. As CGM eligibility expands beyond intensive insulin therapy and over-the-counter glucose sensors reach broader consumer populations, connected metabolic monitoring is moving toward a significantly larger addressable market.

A second driver is U.S. demographic aging. Approximately 64.6 million Americans were aged 65 years or older in 2025, and the older population has been increasing much faster than younger demographic groups. Older adults are disproportionately affected by hypertension, cardiovascular disease, diabetes, COPD, sleep disorders, mobility limitations, heart failure, polypharmacy, and multiple simultaneous chronic conditions. These patients generate strong demand for connected blood pressure monitoring, oxygen monitoring, smart scales, medication-management devices, cardiac sensors, diabetes technologies, fall-risk systems, and multiparameter platforms.

A third driver is the economic pressure to move appropriate care away from expensive institutional settings. Healthcare delivered in a hospital is structurally more resource-intensive than monitoring performed at home. U.S. providers therefore have strong incentives to identify patients who can safely transition from inpatient or outpatient monitoring to home-based surveillance. Connected devices are particularly valuable following cardiac procedures, heart-failure admissions, orthopedic surgery, respiratory exacerbations, and other episodes in which deterioration may be identified through changes in vital signs or symptoms before emergency care becomes necessary.

A fourth driver is the expansion of reimbursement-backed remote patient monitoring. Medicare broadly recognizes remote physiologic monitoring involving connected medical devices that digitally collect and transmit patient information. Medicare payments for RPM services exceeded USD 500 million in 2024, demonstrating that connected monitoring has moved materially beyond experimental deployment. The reimbursement environment gives physicians and provider organizations a financial mechanism for incorporating connected devices into chronic and acute disease management, although billing compliance, patient engagement, sufficient data transmission, and meaningful clinical management remain essential.

A fifth driver is the growth of value-based healthcare. Medicare Advantage organizations, accountable care organizations, risk-bearing physician groups, and health systems operating under shared-savings arrangements have stronger economic incentives to prevent high-cost events than organizations operating entirely under traditional fee-for-service models. Connected home healthcare devices allow these organizations to identify rising-risk patients earlier and concentrate clinical resources on individuals most likely to deteriorate.

A sixth driver is consumer normalization of connected health technology. Smartphones, wireless accessories, smartwatches, wireless scales, home blood pressure monitors, glucose sensors, and sleep technologies have made self-generated health data familiar to a broad segment of the U.S. population. This reduces the behavioral barrier to adoption of medical-grade connected devices. However, consumer familiarity alone does not guarantee clinical adoption. Products that succeed in medical channels must demonstrate measurement accuracy, usable interfaces, reliable connectivity, appropriate regulatory authorization, privacy protection, and an actionable clinical workflow.

A seventh driver is the increasing shortage and uneven geographic distribution of healthcare professionals. Rural areas and smaller communities face significant limitations in access to specialists and chronic-care resources. IoT-enabled devices cannot replace professional care, but they can reduce the information disadvantage associated with geographic distance. Connected devices can allow a clinician in a regional center to monitor a patient living many miles away and determine whether an in-person visit or escalation is required.

Finally, manufacturers are benefiting from improving connectivity architecture. Bluetooth Low Energy, home Wi-Fi, smartphones, embedded cellular modules, cloud infrastructure, application programming interfaces, and interoperable healthcare platforms have reduced the technical friction associated with transmitting data from home devices. Cellular connectivity is particularly important for older or medically complex populations because it can eliminate dependence on smartphone pairing and patient-managed Wi-Fi configuration.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. IoT-enabled home healthcare devices market is increasingly moving from connectivity toward clinical intelligence. Basic transmission of a reading is becoming a minimum capability rather than a meaningful differentiator. The next competitive phase will center on whether devices can generate higher-quality data, reduce patient effort, distinguish clinically meaningful deterioration from normal variation, and integrate alerts into professional workflows without creating unsustainable alarm burden.

Continuous biosensing is one of the most important innovation areas. Continuous glucose monitoring has established the commercial viability of sensor-based, recurring-use home healthcare devices, and similar concepts are influencing cardiovascular, temperature, oxygenation, hydration, sleep, and multimodal physiologic monitoring. The FDA’s expanding focus on sensor-based digital health technologies indicates the growing regulatory importance of wearable and minimally invasive devices designed for use beyond clinical settings.

Over-the-counter connected medical devices are also changing the commercial model. Regulatory clearances for OTC glucose sensors have expanded access beyond traditionally prescribed patient groups. This creates a hybrid healthcare-consumer category in which manufacturers may combine retail acquisition with clinically useful data generation. The strategic challenge is ensuring that consumer accessibility does not reduce the clinical credibility required for healthcare-provider partnerships.

Artificial intelligence is becoming important at the analytics layer. A physician practice managing hundreds or thousands of remotely monitored patients cannot manually review every data point. AI-assisted prioritization can identify abnormal trends, reduce repetitive review, stratify patient risk, and direct clinical attention toward individuals requiring intervention. The commercial value of AI is therefore most significant when it reduces clinical workload rather than simply producing additional dashboards.

Interoperability is another major innovation priority. Providers increasingly resist closed platforms that require separate logins for each device brand. Manufacturers that can feed validated readings into electronic health records, population-health systems, chronic-care platforms, and enterprise command centers may obtain an advantage in large health-system contracts. Device selection is consequently becoming partly an information-architecture decision.

Battery life, form factor, sensor durability, and frictionless onboarding remain equally important. Home healthcare products are used by individuals with widely varying levels of technical ability. A connected device that requires repeated pairing, complex account creation, manual data entry, frequent charging, or troubleshooting can create high dropout rates. Manufacturers are therefore investing in auto-pairing, cellular connectivity, simplified user interfaces, preconfigured devices, longer sensor wear, and caregiver-access functionality.

Cybersecurity and data integrity are also emerging as competitive differentiators. Connected medical devices create persistent data pathways between patients and healthcare organizations. Buyers increasingly scrutinize encryption, authentication, software-update processes, vulnerability management, cloud architecture, data ownership, uptime, and regulatory compliance. A device may provide excellent clinical measurements yet fail enterprise procurement if its cybersecurity posture creates unacceptable risk.

Finally, manufacturers are moving toward disease-specific ecosystems. Instead of selling a single blood pressure monitor or pulse oximeter, companies increasingly combine devices with care protocols, analytics, clinician dashboards, patient applications, education, technical support, and integration services. This changes competition from product versus product to ecosystem versus ecosystem.

 

Segmentation Insights

The U.S. IoT-Enabled Home Healthcare Devices Market is segmented on the basis of product category, application, end user, connectivity technology, and geography.

 

By Product Category

Connected Glucose Monitoring and Diabetes Devices

Connected glucose monitoring represents the largest premium product category in the U.S. market. The segment includes continuous glucose monitors, connected blood glucose meters, smart insulin-delivery interfaces, and related home-use digital diabetes technologies. In the 2025 market model, connected glucose and diabetes devices account for approximately USD 5.7 billion in U.S. revenue.

The segment benefits from high diabetes prevalence, recurring sensor consumption, strong specialist adoption, improved reimbursement, and expanding use of CGM outside intensive insulin therapy. OTC biosensors further extend the potential customer base into non-insulin-treated diabetes and metabolic-health monitoring. Manufacturers competing in this segment increasingly differentiate through sensor wear duration, accuracy, device size, smartphone compatibility, alert performance, automated insulin-delivery integration, data-sharing functionality, and ease of prescribing.

Connected Vital-Sign and Multiparameter Monitoring Devices

Connected blood pressure monitors, smart scales, pulse oximeters, thermometers, and multiparameter home monitoring systems represent an estimated USD 4.3 billion market in 2025. Hypertension provides the largest patient base, with approximately 120 million U.S. adults affected.

This category is attractive to primary-care groups, cardiology practices, home healthcare providers, accountable care organizations, and RPM companies because the devices are relatively inexpensive compared with hospital technology and can be deployed across large populations. The principal competitive issue is moving from commodity hardware toward validated, connected devices capable of generating reliable longitudinal data.

Connected Cardiac Monitoring Devices

Connected cardiac home technologies include wearable ECG patches, handheld ECG devices, ambulatory rhythm monitors, connected cardiac sensors, wearable defibrillation systems, remote implant interfaces, and heart-failure monitoring devices. The category represents approximately USD 3.0 billion of the modeled 2025 market.

Growth is supported by atrial fibrillation detection, post-discharge monitoring, heart-failure management, arrhythmia diagnosis, and wider cardiology adoption of ambulatory monitoring. The strongest platforms are those that combine high-quality signal acquisition with clinically credible interpretation and efficient physician reporting.

Connected Respiratory and Sleep Devices

Connected CPAP systems, home sleep technologies, respiratory monitors, spirometry devices, oxygen-therapy monitoring, pulse oximetry, and other connected respiratory products represent approximately USD 2.4 billion in 2025. Sleep-disordered breathing and chronic respiratory disease provide a large recurring user base.

Connectivity is particularly valuable in respiratory therapy because adherence data can be reviewed remotely and therapy settings or patient support can be adjusted without requiring repeated facility visits. Manufacturers increasingly compete on comfort, adherence, remote troubleshooting, cloud data, and integration with respiratory-care providers.

Smart Medication, Home Diagnostic, Safety and Other Connected Devices

The remaining market, estimated at approximately USD 3.3 billion in 2025, includes smart medication dispensers, connected inhalers, home diagnostic equipment, connected thermometers, wearable physiologic sensors, fall-risk and safety devices with healthcare functionality, and emerging disease-specific home platforms.

This category is fragmented but strategically important because medication adherence and early deterioration frequently determine whether chronic conditions remain controlled. Adoption is expected to accelerate as payers and risk-bearing providers seek more complete visibility into patient behavior between clinical encounters.

 

By Application

Diabetes and Metabolic Disease Management

Diabetes represents the largest disease-specific application due to the penetration of CGM, recurring sensor utilization, expanding eligibility, and the clinical value of continuous rather than intermittent glucose data. Approximately 38 million U.S. adults have diabetes according to established public-health estimates, while broader measurements incorporating undiagnosed disease indicate an even larger metabolic-risk population.

The application is evolving toward integrated management combining glucose data, insulin delivery, dietary information, physical activity, and clinician review. The emergence of OTC glucose sensing additionally expands the commercial opportunity beyond the traditional insulin-treated population.

Cardiovascular and Hypertension Management

Cardiovascular and hypertension applications represent one of the fastest-expanding value pools. Connected blood pressure cuffs, weight scales, ECG monitors, wearable sensors, and cardiac devices allow providers to identify uncontrolled blood pressure, arrhythmia, fluid retention, or other warning signs before a scheduled clinic appointment.

Hypertension alone creates an unusually large addressable market because approximately 120 million adults are affected. The major unmet need is not diagnosis alone but sustained control. Connected monitoring can provide providers with a larger longitudinal dataset for therapy adjustment and adherence assessment.

Respiratory and Sleep Management

COPD, asthma, sleep apnea, chronic respiratory insufficiency, and post-respiratory-event monitoring drive demand for connected pulse oximeters, inhaler technologies, CPAP devices, home spirometry, and oxygen monitoring.

The commercial opportunity is especially significant in older and nonmetropolitan populations where respiratory disease burden can be higher and specialist access lower. Connected respiratory devices allow providers to identify adherence problems or deterioration without requiring a physical encounter for every assessment.

Post-Acute and Transitional Care

Post-discharge monitoring is becoming a strategically important application because the first days and weeks after hospitalization often carry elevated risk of deterioration or readmission. Connected blood pressure monitors, weight scales, oximeters, thermometers, cardiac monitors, and multiparameter kits can create a virtual observation layer after the patient leaves the hospital.

Health systems evaluate these technologies through readmission reduction, emergency-department utilization, length-of-stay economics, nursing workload, and patient satisfaction. Devices that can be deployed rapidly at discharge and require minimal patient configuration are particularly attractive.

Elderly Care, Multimorbidity and Preventive Monitoring

Older adults commonly require simultaneous monitoring of multiple conditions. This supports multiparameter platforms rather than single-disease devices alone. The opportunity includes cardiovascular surveillance, diabetes management, medication adherence, respiratory monitoring, fall-risk management, weight tracking, and caregiver notifications.

This application will expand substantially through 2035 as the older population grows and healthcare systems seek to maintain independence at home for patients who would otherwise require more intensive care environments.

 

By End User

Hospitals and Integrated Health Systems

Hospitals and integrated delivery networks are becoming major institutional purchasers of connected home healthcare devices through hospital-at-home programs, post-discharge monitoring, specialty-care pathways, population-health initiatives, and enterprise RPM programs.

Their purchasing decisions increasingly focus on integration, clinical evidence, security, deployment logistics, total cost per monitored patient, and the ability to reduce avoidable utilization. A low-cost device can lose an enterprise contract if its connectivity failures generate high nursing or technical-support workload.

Physician Practices and Specialty Clinics

Primary-care practices, cardiology groups, endocrinology clinics, pulmonology practices, nephrology providers, and other specialty groups are important users because connected devices extend disease management between visits. Physician adoption is particularly strong where remote monitoring can support reimbursement and improve management of large chronic-care populations.

These buyers prioritize validated devices, simple patient onboarding, reliable data transmission, reimbursement support, and dashboards that minimize alert burden.

Home Healthcare and Post-Acute Providers

Home healthcare agencies are a natural channel for IoT-enabled devices because clinicians already manage patients in residential environments. Connected devices can extend clinical visibility between home visits and allow resources to be targeted toward patients with abnormal trends.

The scale of U.S. home healthcare spending indicates a large existing delivery infrastructure into which connected monitoring can be integrated. As labor shortages constrain visit capacity, technologies that allow each nurse or clinician to oversee more patients will become increasingly valuable.

Payers and Risk-Bearing Care Organizations

Medicare Advantage plans, accountable care organizations, Medicaid managed-care plans, self-insured employers, and other risk-bearing entities are becoming more influential purchasers or sponsors. Their economic interest centers on lowering total medical cost rather than generating device revenue.

Devices that demonstrate reductions in emergency visits, hospital admissions, readmissions, or disease complications can therefore support population-level deployments. Procurement usually requires evidence on engagement, adherence, clinical outcomes, member retention, and cost savings.

Patients, Caregivers and Consumer Health Channels

Direct-to-consumer channels are expanding rapidly, particularly for glucose monitoring, blood pressure monitoring, cardiac screening, sleep management, smart scales, and home diagnostics. OTC regulatory pathways and retail distribution are lowering barriers between medical devices and consumer healthcare.

The distinction between consumer and clinical channels is becoming less rigid. Devices purchased directly by patients may eventually generate data used by physicians, while provider-prescribed devices increasingly use consumer-grade interfaces and smartphone experiences.

 

By Connectivity Technology

Bluetooth and Smartphone-Connected Devices

Bluetooth remains a major connectivity architecture because it provides low-power communication between medical devices and smartphones or dedicated hubs. It is particularly common in glucose meters, blood pressure monitors, pulse oximeters, scales, ECG devices, and portable diagnostic products.

The advantage is low connectivity cost and widespread smartphone compatibility. The limitation is dependence on pairing, application setup, smartphone availability, and patient technical ability.

Wi-Fi and Home Network-Connected Devices

Wi-Fi is widely used in devices that remain in the home, including CPAP systems, smart medication devices, scales, monitoring hubs, and multiparameter platforms. It can support high-volume data transmission but depends on stable household connectivity and correct configuration.

Manufacturers are increasingly simplifying onboarding through automated network setup and remote support because connectivity failure directly affects patient adherence and provider confidence.

Cellular-Enabled Devices

Cellular connectivity is one of the fastest-growing technologies because it reduces patient setup requirements. Devices can be shipped preconfigured and begin transmitting after activation without requiring a smartphone or household Wi-Fi.

This architecture is especially attractive for Medicare populations, post-discharge monitoring, rural deployments, and enterprise RPM programs. Although cellular modules and data plans increase device cost, the reduction in technical-support workload can improve total program economics.

NFC, Sensor-Based and Short-Range Connected Technologies

Near-field communication and specialized wearable sensor technologies are important in glucose monitoring, medication systems, diagnostic products, and other applications where low-power data exchange is required. Sensor innovation will increasingly determine the feasibility of longer wear, smaller form factors, and continuous physiologic monitoring.

Hybrid and Multi-Connectivity Platforms

The market is moving toward devices capable of using multiple connectivity pathways. Hybrid architecture may combine Bluetooth, Wi-Fi, cellular, cloud connectivity, and caregiver access to increase transmission reliability. Enterprise buyers increasingly value platforms that maintain data continuity even when one connectivity pathway fails.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. IoT-Enabled Home Healthcare Devices Market is geographically segmented into the South, West, Northeast, and Midwest. Regional performance differs based on population growth, age distribution, chronic-disease prevalence, Medicare enrollment, broadband access, rurality, health-system concentration, home healthcare utilization, technology adoption, and penetration of value-based care.

The South is the largest regional market, while the West is expected to record the fastest growth through 2035. The Northeast remains a premium, evidence-intensive market with strong academic and integrated health-system adoption, while the Midwest offers a large base of chronic-disease demand and significant opportunities for connected care across geographically dispersed populations.

South

The South represented an estimated USD 6.64 billion in 2025, equivalent to approximately 35.5% of the national market. On the current trajectory, the regional opportunity could approach USD 29.84 billion by 2035.

The region includes Delaware, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, West Virginia, Alabama, Kentucky, Mississippi, Tennessee, Arkansas, Louisiana, Oklahoma, and Texas, with the District of Columbia operating as an additional high-density healthcare market.

Texas and Florida are the two most commercially important state markets. Texas combines a population above 30 million with major healthcare ecosystems in Houston, Dallas-Fort Worth, Austin, and San Antonio. Large integrated systems, extensive Medicare Advantage penetration, diabetes and hypertension burden, rural access gaps, and rapid suburban growth create strong demand for connected cardiometabolic monitoring, post-discharge devices, respiratory technologies, and home diagnostics.

Florida is especially important because of its large older population. The state provides an unusually favorable demographic environment for blood pressure monitoring, cardiac rhythm technologies, smart scales, diabetes devices, respiratory equipment, medication support, and home-care monitoring. Medicare-focused and risk-bearing care models make Florida an important commercialization market for companies demonstrating reductions in acute-care utilization.

North Carolina and Georgia are emerging as high-growth connected-care markets because of population expansion, major academic healthcare centers, sophisticated integrated delivery networks, and increasing technology adoption. Charlotte, Raleigh-Durham, Atlanta, and surrounding metropolitan areas provide strong provider environments for RPM deployment and enterprise digital-health partnerships.

Virginia and Maryland have advanced healthcare infrastructure, strong physician density, proximity to federal healthcare institutions, sophisticated payer markets, and large suburban populations. Their commercial opportunity is particularly attractive for premium monitoring platforms, connected cardiac products, digital diagnostics, and interoperable systems.

Tennessee is an important healthcare-services hub with significant corporate healthcare activity centered around Nashville. This creates an attractive environment for partnerships involving home healthcare, care-management platforms, and remote monitoring. Kentucky and West Virginia have smaller device markets but higher chronic-disease burdens in many communities, strengthening the clinical case for scalable hypertension, respiratory, diabetes, and cardiac monitoring.

Alabama, Mississippi, Louisiana, Arkansas, and Oklahoma represent important need-driven markets. These states face high cardiometabolic disease burden and substantial rural populations. Device manufacturers must, however, account for broadband variability, household affordability, provider shortages, and lower ability to support complex patient onboarding. Cellular-enabled and preconfigured monitoring devices may therefore have stronger deployment economics than systems requiring advanced consumer technology.

South Carolina and Delaware are smaller in absolute revenue but remain strategically attractive through older-population growth, expanding retirement communities, and proximity to larger regional health systems.

The South’s long-term leadership is supported by population migration, aging, high diabetes and hypertension burden, increasing Medicare enrollment, large home-health utilization, and major health-system expansion. For manufacturers, the region offers high volume but requires differentiated state strategies. Premium integrated platforms may perform well in Texas, Florida, Virginia, Maryland, North Carolina, and Georgia, while simplified cellular and payer-sponsored models can be more relevant in rural and lower-access states.

West

The West represented approximately USD 4.69 billion in 2025 and is expected to be the fastest-growing U.S. region, potentially reaching USD 22.06 billion by 2035.

The region includes California, Washington, Oregon, Nevada, Arizona, New Mexico, Colorado, Utah, Idaho, Montana, Wyoming, Alaska, and Hawaii.

California is the region’s largest and most influential state market. Its importance extends beyond population size because the state combines major academic medical centers, sophisticated integrated health systems, digital-health companies, medical-device developers, venture-backed technology firms, consumer technology companies, and a large commercially insured population.

California is often an early market for continuous sensing, AI-supported monitoring, connected cardiac devices, home diagnostics, glucose platforms, and software-integrated devices. Procurement is sophisticated, however, and buyers frequently require interoperability, cybersecurity documentation, demonstrated clinical outcomes, and economic evidence before committing to enterprise-scale deployments.

Arizona and Nevada are high-growth markets driven by rapid population expansion and aging demographics. Both are increasingly important for diabetes, hypertension, cardiovascular, respiratory, and senior-care monitoring. Arizona’s large retirement population and expanding Phoenix healthcare ecosystem make it especially relevant for Medicare-oriented connected-care strategies.

Washington and Oregon have strong integrated delivery networks and relatively advanced digital-health adoption. Providers in these states can be receptive to connected monitoring when products fit population-health and value-based-care workflows. Connected respiratory management, hypertension monitoring, diabetes technologies, and post-acute programs are particularly relevant.

Colorado and Utah combine younger technology-oriented populations with expanding health systems and significant digital-health activity. These states are attractive for manufacturers testing new consumer-clinical hybrid products, connected diagnostics, and preventive monitoring.

Idaho, Montana, Wyoming, New Mexico, and Alaska highlight the geographic-access value of connected healthcare. Population density is lower, travel distances can be substantial, and specialty access may require regional referral. Cellular-enabled devices, asynchronous monitoring, and home diagnostics can therefore provide disproportionate clinical value even when absolute device revenue is smaller.

Hawaii is a distinct remote-care market because inter-island geography can complicate access to specialty services. Connected monitoring has potential in diabetes, cardiovascular disease, respiratory management, and post-discharge care, although logistics and payer relationships materially influence commercial scale.

The West is expected to gain national market share because it combines strong technology adoption with healthcare innovation. The most successful companies will convert early innovation into scalable provider workflows rather than relying on consumer enthusiasm alone.

Northeast

The Northeast represented approximately USD 4.08 billion in 2025 and could reach approximately USD 16.46 billion by 2035.

The region includes Maine, New Hampshire, Vermont, Massachusetts, Rhode Island, Connecticut, New York, New Jersey, and Pennsylvania.

New York is the largest state opportunity in the Northeast. Its large population, major academic medical centers, extensive hospital networks, substantial Medicaid and Medicare populations, and high density of specialty providers create demand across diabetes, cardiac, respiratory, elderly-care, and post-acute connected devices.

New York City represents a technologically advanced market, while upstate communities create a different need profile involving access, chronic disease, aging, and geographic dispersion. Vendors therefore need both enterprise integration capabilities and scalable remote deployment models.

Massachusetts is one of the country’s most strategically influential healthcare markets despite its smaller population. Boston’s academic medical centers, biotechnology industry, digital-health ecosystem, research infrastructure, and early-adopter clinicians make the state important for clinical validation and commercialization of novel connected devices.

Pennsylvania and New Jersey provide large patient populations and extensive health-system infrastructure. Pennsylvania combines major urban health systems in Philadelphia and Pittsburgh with rural communities that can benefit from home monitoring. New Jersey has high physician density, extensive life-sciences activity, and proximity to major New York and Philadelphia healthcare markets.

Connecticut and Rhode Island are smaller but relatively high-value markets with strong healthcare access and concentrated provider systems. Maine, Vermont, and New Hampshire have aging populations and significant rural areas, creating attractive use cases for home monitoring even though their total market sizes are lower.

The Northeast is generally more mature and grows more slowly than the West or South, but average revenue per monitored patient can be attractive because of high-acuity provider networks, premium technology adoption, and sophisticated reimbursement environments.

Procurement is highly evidence driven. Vendors typically need clinical validation, security documentation, workflow integration, and credible health-economic outcomes. Academic partnerships in this region can influence national adoption because prominent health systems often participate in clinical trials, guidelines, and professional education.

Midwest

The Midwest represented approximately USD 3.29 billion in 2025 and could reach approximately USD 12.73 billion by 2035.

The region includes Ohio, Indiana, Illinois, Michigan, Wisconsin, Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, and South Dakota.

Illinois is the region’s largest commercial opportunity, supported by Chicago’s major academic hospitals, integrated delivery networks, physician practices, and large population. Connected cardiac, diabetes, hypertension, home diagnostic, and post-discharge monitoring programs have significant addressable potential.

Ohio is strategically important because of its extensive hospital infrastructure, nationally recognized healthcare systems, aging population, and high chronic-disease burden in many communities. Cleveland, Columbus, and Cincinnati provide strong healthcare commercialization centers.

Michigan offers a large cardiometabolic and chronic-care patient base. Detroit and other major urban systems provide enterprise opportunities, while rural and northern communities create additional need for connected care.

Minnesota has particular strategic significance because of its medical-device ecosystem, health-plan infrastructure, integrated healthcare organizations, and longstanding expertise in medical technology. It is an influential market for connected cardiac technologies, remote monitoring, and enterprise medical-device innovation.

Wisconsin, Indiana, and Missouri provide stable demand across home healthcare, cardiometabolic management, respiratory care, and post-acute monitoring. Large regional healthcare systems can create meaningful multi-facility contracts for manufacturers offering standardized platforms.

Iowa, Kansas, Nebraska, North Dakota, and South Dakota are smaller markets by absolute revenue but highly relevant for remote-care economics. Rural communities, aging populations, and long travel distances to specialty providers increase the value of devices capable of reliably transmitting physiologic data from patients’ homes.

The Midwest is expected to grow more slowly than the South and West but remains strategically attractive because of its large base of chronic disease, strong integrated delivery networks, medical-device expertise, and significant rural-health need. Companies capable of combining competitive hardware economics with cellular connectivity, clinician workflow support, and reliable service infrastructure can develop durable positions across the region.

At a national level, state-level commercial priority through 2035 is expected to concentrate particularly in California, Texas, Florida, New York, Pennsylvania, Illinois, Ohio, New Jersey, North Carolina, Georgia, Massachusetts, Michigan, Arizona, Washington, Virginia, Tennessee, Minnesota, Colorado, Maryland, and Indiana. However, smaller and rural states may generate disproportionately strong growth for cellular-connected monitoring because the clinical value of avoiding travel and enabling earlier intervention can be higher.

 

Key Market Players

The U.S. IoT-Enabled Home Healthcare Devices Competitive Landscape is fragmented across diabetes, cardiovascular monitoring, respiratory care, vital-sign monitoring, wearable sensing, diagnostics, and home-care platforms. No single company controls the entire connected-home ecosystem, although several global medtech companies hold strong positions in specific high-value categories.

Some of the key companies shaping the U.S. market include Abbott Laboratories, Dexcom, Medtronic, Insulet Corporation, Tandem Diabetes Care, Omron Healthcare, Koninklijke Philips, ResMed, Masimo, Baxter International, GE HealthCare, Roche Diabetes Care, LifeScan, Ascensia Diabetes Care, iRhythm Technologies, VitalConnect, BioIntelliSense, AliveCor, TytoCare, Withings Health Solutions, Current Health/Best Buy Health, ZOLL Medical, Nonin Medical, A&D Medical, and Apple.

Abbott and Dexcom are particularly influential in connected glucose sensing because CGM represents one of the largest recurring-revenue home monitoring categories. Medtronic, Insulet, and Tandem are important in digitally connected diabetes therapy and automated insulin-delivery ecosystems.

Omron, A&D Medical, Withings, and other monitoring companies compete across connected blood pressure and vital-sign measurement. Philips, ResMed, Masimo, Nonin, and Baxter participate in respiratory, sleep, oxygenation, monitoring, and home-care technologies.

iRhythm, AliveCor, VitalConnect, BioIntelliSense, and ZOLL represent important participants in ambulatory cardiac or wearable physiologic monitoring. TytoCare and Current Health illustrate the convergence between connected hardware and broader virtual-care infrastructure.

Apple is strategically relevant because consumer devices increasingly incorporate regulated health functionality and provide data ecosystems that shape patient expectations for usability, sensing, and interoperability. Consumer-technology companies may not compete directly with traditional medical devices in every segment, but they materially influence product design standards and the boundaries between consumer and clinical monitoring.

Competition through 2035 will increasingly center on five capabilities: clinically reliable sensors, frictionless patient onboarding, strong connectivity, healthcare-system integration, and evidence that monitoring changes outcomes or reduces cost. Hardware companies that cannot support data integration risk becoming commoditized suppliers, while software-first platforms without control of reliable device data may face dependence on third-party hardware manufacturers.

 

Recent Developments

Recent developments in the U.S. IoT-Enabled Home Healthcare Devices Market demonstrate how quickly connected care is moving toward continuous, accessible, and reimbursement-supported monitoring.

In March 2024, the U.S. FDA cleared the first over-the-counter continuous glucose monitor, expanding access to connected glucose sensing without requiring traditional prescription pathways for the eligible adult population. Abbott subsequently received FDA clearances for its Lingo and Libre Rio glucose systems in 2024. These developments are important because they expand connected biosensing beyond conventional prescription diabetes management and create a broader retail channel for clinically relevant physiologic information.

Remote patient monitoring reimbursement has also continued to expand in economic significance. Medicare payments for RPM exceeded USD 500 million in 2024. The level of spending demonstrates meaningful provider adoption, but it has also increased regulatory scrutiny around appropriate billing, device use, patient relationships, and whether monitoring services are actually being delivered as intended.

In September 2025, the FDA issued a safety communication regarding unauthorized devices claiming to measure or estimate blood pressure. The development is commercially important because connected hypertension monitoring is becoming a major home-healthcare category, yet inaccurate measurements can create direct clinical risk. Regulatory authorization and measurement validation are therefore likely to become stronger differentiators as low-cost consumer products enter the category.

The FDA’s growing focus on sensor-based digital health technologies also signals increasing regulatory attention to wearable and minimally invasive devices designed for continuous or spot-check monitoring outside conventional healthcare settings. This supports innovation while raising expectations around data integrity, clinical validation, software performance, cybersecurity, and appropriate claims.

In 2026, CMS introduced the ACCESS Model as a technology-supported chronic-care initiative targeting conditions including high blood pressure and diabetes. The model incorporates approaches such as remote monitoring, wearables, coaching, and medication management, with provider payments linked substantially to patient outcomes. Although individual commercial impacts will depend on participation and performance, the program reinforces the strategic direction toward longitudinal technology-enabled chronic care.

In June 2026, the FDA expanded OTC access to Dexcom’s Stelo glucose biosensor for eligible pediatric users aged two years and older who do not use insulin. This illustrates the potential for connected home healthcare devices to expand into broader age groups and preventive or non-intensive management populations as evidence and regulatory pathways evolve.

These developments collectively indicate that the next growth phase will be characterized by wider access but greater accountability. Device companies will be expected to prove that connected measurements are accurate, securely transmitted, used appropriately, and translated into meaningful patient or provider action.

 

Conclusion

The U.S. IoT-Enabled Home Healthcare Devices Market Size & Share is positioned for significant expansion from approximately USD 18.70 billion in 2025 to USD 81.08 billion by 2035, representing a CAGR of approximately 15.80% during 2026–2035.

The market’s long-term strength is supported by structural rather than temporary factors. The United States has an aging population, a large burden of hypertension, diabetes, cardiovascular disease and respiratory illness, high healthcare expenditure, increasing adoption of value-based care, established remote monitoring reimbursement, mature digital infrastructure, and growing pressure to manage patients outside expensive institutional settings.

The most attractive product opportunities will develop in continuous glucose sensing, connected cardiovascular monitoring, blood pressure management, wearable biosensors, respiratory and sleep technologies, cellular-enabled multiparameter devices, post-discharge monitoring, home diagnostics, and medication-management systems.

The market will also become increasingly selective. Connectivity alone will not sustain premium pricing. Devices will need to demonstrate accuracy, patient adherence, dependable data transmission, cybersecurity, interoperability, measurable clinical value, and low workflow burden. Providers do not require more raw information; they require usable information that allows clinical teams to intervene appropriately and efficiently.

From a procurement standpoint, health systems and risk-bearing organizations will increasingly evaluate the cost of the entire monitoring pathway. Device acquisition cost will be assessed against onboarding expense, connectivity cost, technical support, clinical labor, alert volume, replacement requirements, patient dropout, reimbursement opportunity, avoided utilization, and measurable outcomes.

Regional opportunity will remain led by the South, supported by Texas, Florida and other rapidly expanding states, while the West is expected to record the fastest percentage growth because of strong technology adoption and healthcare innovation. The Northeast will remain a premium evidence-driven market, and the Midwest will offer durable opportunities across chronic disease and rural connected care.

For manufacturers, investors, healthcare providers, distributors, and technology companies evaluating this market, the central strategic question is not whether home-based healthcare will become more connected. That transition is already underway. The more important issue is which connected devices become embedded in routine clinical pathways and which remain optional consumer technologies.

Companies that combine medical-grade measurement, frictionless connectivity, recurring patient engagement, provider interoperability, reimbursement alignment, regulatory discipline, and demonstrable healthcare economics will be best positioned to capture the next decade of growth in the U.S. IoT-Enabled Home Healthcare Devices Market.

 

TABLE OF CONTENT

1. U.S. IoT-Enabled Home Healthcare Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. IoT-Enabled Home Healthcare Device Manufacturers
1.6.2. Sensor, Semiconductor and Connectivity Component Suppliers
1.6.3. Remote Patient Monitoring Platform Providers
1.6.4. Hospitals and Integrated Delivery Networks
1.6.5. Physician Practices and Specialty Clinics
1.6.6. Home Healthcare and Post-Acute Care Providers
1.6.7. Medicare Advantage Plans, Payers and Risk-Bearing Organizations
1.6.8. Pharmacies, DME Suppliers, Distributors and Retail Channels
1.6.9. Patients, Caregivers and Consumer Health Users
1.6.10. FDA, CMS and Healthcare Regulatory Stakeholders

What this section provides: This section defines the U.S. IoT-enabled home healthcare devices market boundary, study scope, methodology, assumptions and stakeholder ecosystem, enabling clients to understand how connected home-use medical device revenues are measured, validated and differentiated from standalone telehealth, software-only and general wellness markets.

2. U.S. IoT-Enabled Home Healthcare Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. U.S. Market Size, 2021–2035 (US$ Billion)
2.8. Forecast CAGR Analysis, 2026–2035
2.9. High-Growth Device Categories
2.10. High-Growth Clinical Applications
2.11. Key State-Level Opportunity Markets
2.12. Strategic Opportunity Snapshot

What this section provides: This section gives decision-makers a concise view of market size, historical development, forecast growth, high-value device categories, priority applications, regional opportunities and the most important strategic themes shaping the U.S. connected home healthcare market.

3. U.S. IoT-Enabled Home Healthcare Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising U.S. Chronic Disease Burden
3.1.2. Rapid Growth of the U.S. Population Aged 65 Years and Above
3.1.3. Expansion of Remote Patient Monitoring Adoption
3.1.4. Shift from Institutional Care to Home-Based Healthcare
3.1.5. Increasing Adoption of Continuous Glucose Monitoring
3.1.6. Growing Demand for Connected Hypertension Management
3.1.7. Expansion of Value-Based Care and Risk-Sharing Models
3.1.8. Increasing Hospital Focus on Readmission Reduction
3.1.9. Growth of Hospital-at-Home and Transitional Care Programs
3.1.10. Improving Cellular, Wi-Fi and Smartphone Connectivity

3.2. Restraints and Their Impact Analysis
3.2.1. Device and Platform Cost Constraints
3.2.2. Patient Digital Literacy and Technology Adoption Barriers
3.2.3. Connectivity Failure and Device Onboarding Complexity
3.2.4. Data Privacy and Cybersecurity Concerns
3.2.5. Clinical Alert Fatigue and Workflow Burden
3.2.6. Fragmented Reimbursement Across Payers
3.2.7. Device Accuracy and Validation Requirements

3.3. Opportunities and Their Impact Analysis
3.3.1. Continuous Biosensing and Wearable Medical Sensors
3.3.2. Over-the-Counter Connected Medical Devices
3.3.3. Cellular-Enabled Remote Patient Monitoring Devices
3.3.4. AI-Assisted Remote Monitoring and Alert Prioritization
3.3.5. Connected Cardiometabolic Disease Management
3.3.6. Smart Medication Adherence Technologies
3.3.7. Home Diagnostics and Virtual Examination Devices
3.3.8. Rural and Underserved Population Monitoring
3.3.9. Medicare Advantage and Accountable Care Organization Partnerships
3.3.10. Enterprise Connected-Care Device Platforms

3.4. Challenges and Their Impact Analysis
3.4.1. Device Interoperability Challenges
3.4.2. EHR Integration Complexity
3.4.3. Long-Term Patient Adherence
3.4.4. Data Overload and Clinical Prioritization
3.4.5. Reimbursement Compliance Risk
3.4.6. Scaling Technical Support Across Large Patient Populations

3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Home-Based Care Cost Economics Analysis
3.8. Connected Device Procurement Behavior Analysis
3.9. Patient Onboarding and Engagement Economics
3.10. Remote Monitoring Program ROI Analysis

What this section provides: This section explains the demographic, clinical, reimbursement, technological and operational forces shaping market demand and helps clients assess adoption drivers, barriers, investment opportunities, execution risks and the economics of scaling connected home healthcare programs.

4. U.S. IoT-Enabled Home Healthcare Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal

4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry

4.3. Pricing Trend Analysis, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Sensor and Semiconductor Supply Ecosystem
4.6. Connected Device Manufacturing and Contract Manufacturing Landscape
4.7. Cloud Connectivity and Data Infrastructure Landscape
4.8. Application & Innovation Landscape
4.9. FDA Regulatory Framework for Connected Home-Use Medical Devices
4.10. Software as a Medical Device and Device-Software Integration Considerations
4.11. CMS Remote Patient Monitoring Reimbursement Landscape
4.12. Medicare Advantage and Commercial Payer Coverage Environment
4.13. HIPAA, Data Privacy and Healthcare Cybersecurity Landscape
4.14. Interoperability and EHR Integration Framework
4.15. Import/Export Restrictions & Tariff Impact
4.16. Government Initiatives Supporting Home-Based and Digital Care
4.17. Impact of Escalating Geopolitical and Semiconductor Supply Risks
4.18. Health System Value Analysis and Digital Health Procurement Framework
4.19. Patient Data Ownership and Consent Considerations

What this section provides: This section provides a comprehensive assessment of the regulatory, reimbursement, cybersecurity, technology, supply-chain, pricing and procurement environment affecting IoT-enabled medical devices used in U.S. homes.

5. U.S. IoT-Enabled Home Healthcare Devices Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.1.2. Segment Market Size and Forecast, 2021–2035 (US$ Billion)

5.2. Connected Glucose Monitoring and Diabetes Devices
5.2.1. Continuous Glucose Monitoring Systems
5.2.2. Connected Blood Glucose Meters
5.2.3. Smart Insulin Delivery and Connected Diabetes Devices
5.2.4. OTC Glucose Biosensors
5.2.5. Connected Diabetes Monitoring Accessories

5.3. Connected Vital-Sign and Multiparameter Monitoring Devices
5.3.1. Connected Blood Pressure Monitors
5.3.2. Connected Pulse Oximeters
5.3.3. Smart Weight Scales
5.3.4. Connected Thermometers
5.3.5. Multiparameter Home Patient Monitors

5.4. Connected Cardiac Monitoring Devices
5.4.1. Wearable ECG Monitors
5.4.2. Patch-Based Cardiac Monitoring Devices
5.4.3. Handheld and Portable ECG Devices
5.4.4. Connected Heart Failure Monitoring Devices
5.4.5. Remote Cardiac Device Monitoring Systems

5.5. Connected Respiratory and Sleep Devices
5.5.1. Connected CPAP and PAP Devices
5.5.2. Connected Spirometers
5.5.3. Connected Oxygen Therapy Monitoring Devices
5.5.4. Connected Respiratory Monitoring Devices
5.5.5. Connected Sleep Monitoring Devices

5.6. Smart Medication, Home Diagnostic, Safety and Other Connected Devices
5.6.1. Smart Medication Dispensers
5.6.2. Connected Inhalers
5.6.3. IoT-Enabled Home Diagnostic Devices
5.6.4. Connected Fall Detection and Safety Devices
5.6.5. Wearable Physiological Sensors
5.6.6. Other IoT-Enabled Home Healthcare Devices

What this section provides: This section identifies the connected home healthcare device categories expected to generate the largest revenue pools and fastest growth and evaluates how recurring sensors, monitoring hardware and home diagnostic technologies are reshaping the U.S. market.

6. U.S. IoT-Enabled Home Healthcare Devices Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Segment Market Size and Forecast, 2021–2035 (US$ Billion)

6.2. Diabetes and Metabolic Disease Management
6.2.1. Insulin-Dependent Diabetes Management
6.2.2. Non-Insulin-Treated Diabetes Monitoring
6.2.3. Metabolic Health Monitoring
6.2.4. Obesity and Cardiometabolic Risk Monitoring

6.3. Cardiovascular and Hypertension Management
6.3.1. Hypertension Monitoring
6.3.2. Arrhythmia Detection and Monitoring
6.3.3. Heart Failure Monitoring
6.3.4. Post-Cardiac Procedure Monitoring
6.3.5. Cardiovascular Risk Surveillance

6.4. Respiratory and Sleep Management
6.4.1. COPD Monitoring
6.4.2. Asthma Management
6.4.3. Sleep Apnea Management
6.4.4. Home Oxygen Monitoring
6.4.5. Respiratory Rehabilitation Monitoring

6.5. Post-Acute and Transitional Care
6.5.1. Post-Hospital Discharge Monitoring
6.5.2. Hospital-at-Home Monitoring
6.5.3. Post-Surgical Monitoring
6.5.4. Rehabilitation and Recovery Monitoring
6.5.5. High-Risk Patient Surveillance

6.6. Elderly Care, Multimorbidity and Preventive Monitoring
6.6.1. Aging-in-Place Monitoring
6.6.2. Multichronic Disease Monitoring
6.6.3. Medication Adherence Monitoring
6.6.4. Fall and Safety Monitoring
6.6.5. Preventive and Wellness-Oriented Clinical Monitoring

What this section provides: This section evaluates demand by major clinical use case and enables clients to identify disease areas and care pathways where IoT-enabled home healthcare devices offer the greatest potential for adoption, recurring utilization and healthcare cost reduction.

7. U.S. IoT-Enabled Home Healthcare Devices Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Segment Market Size and Forecast, 2021–2035 (US$ Billion)

7.2. Hospitals and Integrated Health Systems
7.2.1. Hospital-at-Home Programs
7.2.2. Transitional Care Programs
7.2.3. Population Health Programs
7.2.4. Enterprise Remote Patient Monitoring Programs

7.3. Physician Practices and Specialty Clinics
7.3.1. Primary Care Practices
7.3.2. Cardiology Practices
7.3.3. Endocrinology and Diabetes Clinics
7.3.4. Pulmonology and Sleep Clinics
7.3.5. Other Specialty Practices

7.4. Home Healthcare and Post-Acute Care Providers
7.4.1. Medicare-Certified Home Health Agencies
7.4.2. Private Home Healthcare Providers
7.4.3. Rehabilitation and Post-Acute Providers
7.4.4. Skilled Nursing Transition Programs

7.5. Payers and Risk-Bearing Care Organizations
7.5.1. Medicare Advantage Organizations
7.5.2. Accountable Care Organizations
7.5.3. Medicaid Managed Care Organizations
7.5.4. Commercial Health Plans
7.5.5. Self-Insured Employers and Population Health Programs

7.6. Patients, Caregivers and Consumer Health Channels
7.6.1. Direct-to-Consumer Users
7.6.2. Family and Informal Caregivers
7.6.3. Retail Pharmacy Customers
7.6.4. E-Commerce Healthcare Device Buyers
7.6.5. OTC Connected Medical Device Users

What this section provides: This section identifies the healthcare organizations, risk-bearing entities, professional users and consumer groups driving connected device purchasing and adoption across U.S. home-based care.

8. U.S. IoT-Enabled Home Healthcare Devices Market – By Connectivity Technology

8.1. Overview
8.1.1. Segment Share Analysis, By Connectivity Technology, 2025 & 2035 (%)
8.1.2. Segment Market Size and Forecast, 2021–2035 (US$ Billion)

8.2. Bluetooth and Smartphone-Connected Devices
8.2.1. Bluetooth Low Energy Devices
8.2.2. Smartphone Application-Linked Devices
8.2.3. Bluetooth Gateway-Based Monitoring Devices

8.3. Wi-Fi and Home Network-Connected Devices
8.3.1. Direct Wi-Fi Medical Devices
8.3.2. Home Monitoring Hub-Connected Devices
8.3.3. Cloud-Connected Home Healthcare Devices

8.4. Cellular-Enabled Devices
8.4.1. 4G/LTE-Enabled Devices
8.4.2. 5G-Enabled Devices
8.4.3. Embedded SIM and Preconfigured Cellular Devices
8.4.4. Cellular Remote Monitoring Hubs

8.5. NFC, Sensor-Based and Short-Range Connected Technologies
8.5.1. Near-Field Communication Devices
8.5.2. Wearable Sensor Communication Technologies
8.5.3. Low-Power Short-Range Healthcare Connectivity

8.6. Hybrid and Multi-Connectivity Platforms
8.6.1. Bluetooth + Wi-Fi Platforms
8.6.2. Bluetooth + Cellular Platforms
8.6.3. Wi-Fi + Cellular Platforms
8.6.4. Multi-Protocol Enterprise Connected Devices

What this section provides: This section assesses the connectivity architectures enabling U.S. home healthcare devices and compares their scalability, patient usability, technical-support requirements, reliability and suitability for enterprise remote monitoring.

9. U.S. IoT-Enabled Home Healthcare Devices Market: Market Access, Reimbursement & Procurement Landscape

9.1. Overview
9.2. CMS Remote Patient Monitoring Reimbursement Framework
9.2.1. Remote Physiologic Monitoring Device Supply
9.2.2. Remote Physiologic Monitoring Treatment Management
9.2.3. Patient Eligibility and Data Transmission Considerations
9.2.4. Reimbursement Compliance and Documentation Requirements

9.3. Medicare Advantage Connected-Care Adoption
9.4. Medicaid and State-Level Coverage Considerations
9.5. Commercial Payer Coverage and Employer Programs
9.6. Hospital and Integrated Delivery Network Procurement
9.7. Physician Practice Procurement and RPM Partnerships
9.8. Home Healthcare Agency Procurement
9.9. DME and Specialty Distributor Channels
9.10. Retail Pharmacy Distribution
9.11. Direct-to-Consumer and E-Commerce Distribution
9.12. Enterprise Device Contracting and Volume Pricing
9.13. Subscription, Device-as-a-Service and Recurring Revenue Models
9.14. Patient Out-of-Pocket Economics
9.15. Procurement Decision Criteria
9.15.1. Clinical Accuracy
9.15.2. FDA Regulatory Status
9.15.3. Connectivity Reliability
9.15.4. Cybersecurity
9.15.5. EHR Interoperability
9.15.6. Patient Adherence
9.15.7. Technical Support Burden
9.15.8. Total Cost per Monitored Patient
9.15.9. Reimbursement Capture
9.15.10. Demonstrated Clinical and Economic Outcomes

What this section provides: This section explains how IoT-enabled home healthcare devices enter the U.S. market, how reimbursement influences adoption, how health systems and physician groups evaluate connected technologies and which commercial models are most likely to scale.

10. U.S. IoT-Enabled Home Healthcare Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Chronic Disease and Aging Population Analysis
10.1.4. Regional Remote Patient Monitoring Adoption Analysis
10.1.5. Regional Home Healthcare Infrastructure Analysis
10.1.6. Regional Connectivity and Digital Access Analysis
10.1.7. Regional Reimbursement and Procurement Dynamics

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Key Manufacturers and Connected-Care Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.8. West Region Reimbursement, Adoption and Procurement Dynamics

10.2.9. California

10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.9.6. California Connected-Care Adoption, Reimbursement and Procurement Outlook

10.2.10. Washington

10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.10.6. Washington Connected-Care Adoption, Reimbursement and Procurement Outlook

10.2.11. Arizona

10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Connected-Care Adoption, Reimbursement and Procurement Outlook

10.2.12. Colorado

10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Connected-Care Adoption, Reimbursement and Procurement Outlook

10.2.13. Oregon

10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Connected-Care Adoption, Reimbursement and Procurement Outlook

10.2.14. Utah

10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.14.6. Utah Connected-Care Adoption, Reimbursement and Procurement Outlook

10.2.15. Nevada

10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Connected-Care Adoption, Reimbursement and Procurement Outlook

10.2.16. New Mexico

10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Connected-Care Adoption, Reimbursement and Procurement Outlook

10.2.17. Idaho

10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Connected-Care Adoption, Reimbursement and Procurement Outlook

10.2.18. Montana

10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.18.6. Montana Connected-Care Adoption, Reimbursement and Procurement Outlook

10.2.19. Wyoming

10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Connected-Care Adoption, Reimbursement and Procurement Outlook

10.2.20. Alaska

10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Connected-Care Adoption, Reimbursement and Procurement Outlook

10.2.21. Hawaii

10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Connected-Care Adoption, Reimbursement and Procurement Outlook

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Key Manufacturers and Connected-Care Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Reimbursement, Adoption and Procurement Dynamics

10.3.9. New York

10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.9.6. New York Connected-Care Adoption, Reimbursement and Procurement Outlook

10.3.10. Massachusetts

10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Connected-Care Adoption, Reimbursement and Procurement Outlook

10.3.11. New Jersey

10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Connected-Care Adoption, Reimbursement and Procurement Outlook

10.3.12. Pennsylvania

10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Connected-Care Adoption, Reimbursement and Procurement Outlook

10.3.13. Connecticut

10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Connected-Care Adoption, Reimbursement and Procurement Outlook

10.3.14. Maine

10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.14.6. Maine Connected-Care Adoption, Reimbursement and Procurement Outlook

10.3.15. Vermont

10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Connected-Care Adoption, Reimbursement and Procurement Outlook

10.3.16. New Hampshire

10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Connected-Care Adoption, Reimbursement and Procurement Outlook

10.3.17. Rhode Island

10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Connected-Care Adoption, Reimbursement and Procurement Outlook

10.3.18. Delaware

10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Connected-Care Adoption, Reimbursement and Procurement Outlook

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Key Manufacturers and Connected-Care Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.8. South Region Reimbursement, Adoption and Procurement Dynamics

10.4.9. Texas

10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.9.6. Texas Connected-Care Adoption, Reimbursement and Procurement Outlook

10.4.10. Florida

10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.10.6. Florida Connected-Care Adoption, Reimbursement and Procurement Outlook

10.4.11. Georgia

10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Connected-Care Adoption, Reimbursement and Procurement Outlook

10.4.12. North Carolina

10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Connected-Care Adoption, Reimbursement and Procurement Outlook

10.4.13. Tennessee

10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Connected-Care Adoption, Reimbursement and Procurement Outlook

10.4.14. South Carolina

10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Connected-Care Adoption, Reimbursement and Procurement Outlook

10.4.15. Alabama

10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Connected-Care Adoption, Reimbursement and Procurement Outlook

10.4.16. Mississippi

10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Connected-Care Adoption, Reimbursement and Procurement Outlook

10.4.17. Louisiana

10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Connected-Care Adoption, Reimbursement and Procurement Outlook

10.4.18. Arkansas

10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Connected-Care Adoption, Reimbursement and Procurement Outlook

10.4.19. Kentucky

10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Connected-Care Adoption, Reimbursement and Procurement Outlook

10.4.20. Oklahoma

10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Connected-Care Adoption, Reimbursement and Procurement Outlook

10.4.21. Virginia

10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Connected-Care Adoption, Reimbursement and Procurement Outlook

10.4.22. Maryland

10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Connected-Care Adoption, Reimbursement and Procurement Outlook

10.4.23. West Virginia

10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Connected-Care Adoption, Reimbursement and Procurement Outlook

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Key Manufacturers and Connected-Care Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Reimbursement, Adoption and Procurement Dynamics

10.5.9. Illinois

10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Connected-Care Adoption, Reimbursement and Procurement Outlook

10.5.10. Ohio

10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Connected-Care Adoption, Reimbursement and Procurement Outlook

10.5.11. Michigan

10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Connected-Care Adoption, Reimbursement and Procurement Outlook

10.5.12. Minnesota

10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Connected-Care Adoption, Reimbursement and Procurement Outlook

10.5.13. Indiana

10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Connected-Care Adoption, Reimbursement and Procurement Outlook

10.5.14. Wisconsin

10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Connected-Care Adoption, Reimbursement and Procurement Outlook

10.5.15. Missouri

10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Connected-Care Adoption, Reimbursement and Procurement Outlook

10.5.16. Iowa

10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Connected-Care Adoption, Reimbursement and Procurement Outlook

10.5.17. Kansas

10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Connected-Care Adoption, Reimbursement and Procurement Outlook

10.5.18. Nebraska

10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Connected-Care Adoption, Reimbursement and Procurement Outlook

10.5.19. North Dakota

10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Connected-Care Adoption, Reimbursement and Procurement Outlook

10.5.20. South Dakota

10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Connected-Care Adoption, Reimbursement and Procurement Outlook

What this section provides: This section delivers detailed regional and state-level analysis across all 50 U.S. states, helping clients identify priority geographies, chronic-disease demand centers, aging-population markets, remote-monitoring adoption hotspots, connectivity requirements and state-level commercial opportunities.

11. U.S. IoT-Enabled Home Healthcare Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Competitive Intensity Analysis
11.3. Company Positioning Matrix
11.3.1. Leaders
11.3.2. Challengers
11.3.3. Innovators
11.3.4. Emerging Players

11.4. Competitive Benchmarking by Product Category
11.5. Competitive Benchmarking by Clinical Application
11.6. Connected Device Ecosystem and Partnership Analysis
11.7. Mergers, Acquisitions and Strategic Investments
11.8. Company Profiles

11.8.1. Abbott Laboratories
11.8.2. Dexcom, Inc.
11.8.3. Medtronic plc
11.8.4. Insulet Corporation
11.8.5. Tandem Diabetes Care, Inc.
11.8.6. Omron Healthcare, Inc.
11.8.7. Koninklijke Philips N.V.
11.8.8. ResMed Inc.
11.8.9. Masimo Corporation
11.8.10. Baxter International Inc.
11.8.11. GE HealthCare Technologies Inc.
11.8.12. Roche Diabetes Care
11.8.13. LifeScan, Inc.
11.8.14. Ascensia Diabetes Care Holdings AG
11.8.15. iRhythm Technologies, Inc.
11.8.16. VitalConnect, Inc.
11.8.17. BioIntelliSense, Inc.
11.8.18. AliveCor, Inc.
11.8.19. TytoCare Ltd.
11.8.20. Withings Health Solutions
11.8.21. Current Health / Best Buy Health
11.8.22. ZOLL Medical Corporation
11.8.23. Nonin Medical, Inc.
11.8.24. A&D Medical
11.8.25. Apple Inc.

Note: Each company profile will include company overview, U.S. IoT-enabled home healthcare device portfolio, core product categories, connected-care strategy, financial positioning where available, FDA and regulatory developments, technology partnerships, distribution strategy, recent product launches, acquisitions and strategic developments.

What this section provides: This section gives clients competitor benchmarking, market-share visibility, connected-device portfolio positioning, innovation direction, channel strategy and strategic intelligence on approximately 25 major companies participating in the U.S. home healthcare connectivity ecosystem.

12. U.S. IoT-Enabled Home Healthcare Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario

12.2. Disruptive Technologies Impact
12.2.1. Continuous and Multi-Analyte Biosensors
12.2.2. AI-Assisted Remote Patient Monitoring
12.2.3. Cellular-First Medical Devices
12.2.4. Smart Medication Management Technologies
12.2.5. Connected Home Diagnostic Platforms
12.2.6. Wearable Cardiac and Physiologic Sensors
12.2.7. Ambient and Contactless Health Monitoring
12.2.8. Generative AI in Patient and Clinical Monitoring Workflows
12.2.9. Digital Biomarkers and Predictive Analytics
12.2.10. Interoperable Multi-Device Home Care Ecosystems

12.3. Emerging Business Trends
12.3.1. Device-as-a-Service Models
12.3.2. Hardware Plus Recurring Monitoring Revenue Models
12.3.3. Payer-Sponsored Device Deployment
12.3.4. Retail-to-Clinical Connected Health Models
12.3.5. Enterprise Connected-Care Platform Consolidation

12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.6. Product Category Opportunity Matrix
12.7. Application Opportunity Matrix
12.8. State-Level Growth Opportunity Matrix
12.9. Technology Adoption Roadmap, 2026–2035

What this section provides: This section prepares clients for future technology shifts, evolving reimbursement models, disruptive connected-care technologies, new commercial models and investment opportunities expected to reshape the U.S. IoT-enabled home healthcare devices market through 2035.

13. U.S. IoT-Enabled Home Healthcare Devices Market: Strategic Recommendations

13.1. Recommendations for Medical Device Manufacturers
13.2. Recommendations for Connected Device and Sensor Developers
13.3. Recommendations for Hospitals and Integrated Health Systems
13.4. Recommendations for Physician Practices and Specialty Clinics
13.5. Recommendations for Home Healthcare Providers
13.6. Recommendations for Medicare Advantage and Commercial Payers
13.7. Recommendations for Investors and Private Equity Firms
13.8. Recommendations for Distributors, DME Suppliers and Retail Channels
13.9. Recommendations for New Entrants and Startups
13.10. Go-to-Market Strategy Considerations
13.11. FDA and Reimbursement Strategy Considerations
13.12. Product Positioning and Portfolio Expansion Guidance
13.13. Pricing and Commercial Model Strategy
13.14. Partnership and Ecosystem Strategy
13.15. State-Level Market Entry Prioritization
13.16. Cybersecurity and Interoperability Strategy
13.17. Clinical Evidence and Health Economic Evidence Strategy

What this section provides: This section converts market intelligence into actionable recommendations for product development, market entry, reimbursement, commercial partnerships, geographic expansion, investment decisions and long-term competitive differentiation.

14. U.S. IoT-Enabled Home Healthcare Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Market Definition Limitation
14.3. Data Use Limitation
14.4. Forecasting Limitation
14.5. Regulatory and Reimbursement Disclaimer
14.6. Legal Disclaimer
14.7. Third-Party Data Disclaimer
14.8. Company and Competitive Intelligence Disclaimer

What this section provides: This section clarifies the report’s scope boundaries, assumptions, forecasting limitations, regulatory considerations, legal conditions and appropriate use of third-party and modeled market data.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. IoT-Enabled Home Healthcare Devices Market: Market Definition and Scope
TABLE 3: U.S. IoT-Enabled Home Healthcare Devices Market: Research Methodology Framework
TABLE 4: U.S. IoT-Enabled Home Healthcare Devices Market: Key Assumptions
TABLE 5: U.S. IoT-Enabled Home Healthcare Devices Market: Market Ecosystem Overview
TABLE 6: U.S. IoT-Enabled Home Healthcare Devices Market: Stakeholder Analysis
TABLE 7: U.S. IoT-Enabled Home Healthcare Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. IoT-Enabled Home Healthcare Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. IoT-Enabled Home Healthcare Devices Market: Market Attractiveness Index
TABLE 10: U.S. IoT-Enabled Home Healthcare Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. IoT-Enabled Home Healthcare Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. IoT-Enabled Home Healthcare Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. IoT-Enabled Home Healthcare Devices Market: Drivers; Impact Analysis
TABLE 14: U.S. IoT-Enabled Home Healthcare Devices Market: Restraints; Impact Analysis
TABLE 15: U.S. IoT-Enabled Home Healthcare Devices Market: Opportunities; Impact Analysis
TABLE 16: U.S. IoT-Enabled Home Healthcare Devices Market: Challenges; Impact Analysis
TABLE 17: U.S. IoT-Enabled Home Healthcare Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 18: U.S. IoT-Enabled Home Healthcare Devices Market: Clinical Workflow Economics Matrix
TABLE 19: U.S. IoT-Enabled Home Healthcare Devices Market: Home-Based Care Cost Economics Matrix
TABLE 20: U.S. IoT-Enabled Home Healthcare Devices Market: Connected Device Procurement Behavior Matrix
TABLE 21: U.S. IoT-Enabled Home Healthcare Devices Market: Patient Onboarding & Engagement Economics
TABLE 22: U.S. IoT-Enabled Home Healthcare Devices Market: Remote Monitoring Program ROI Analysis
TABLE 23: U.S. IoT-Enabled Home Healthcare Devices Market: PESTEL Analysis
TABLE 24: U.S. IoT-Enabled Home Healthcare Devices Market: Porter’s Five Forces Analysis
TABLE 25: U.S. IoT-Enabled Home Healthcare Devices Market: Pricing Trend Analysis, 2025–2035
TABLE 26: U.S. IoT-Enabled Home Healthcare Devices Market: Value Chain Analysis
TABLE 27: U.S. IoT-Enabled Home Healthcare Devices Market: Supply Chain Analysis
TABLE 28: U.S. IoT-Enabled Home Healthcare Devices Market: Sensor & Semiconductor Supply Ecosystem
TABLE 29: U.S. IoT-Enabled Home Healthcare Devices Market: Cloud Connectivity & Data Infrastructure Landscape
TABLE 30: U.S. IoT-Enabled Home Healthcare Devices Market: Application & Innovation Landscape
TABLE 31: U.S. IoT-Enabled Home Healthcare Devices Market: FDA Regulatory Framework Analysis
TABLE 32: U.S. IoT-Enabled Home Healthcare Devices Market: CMS Remote Patient Monitoring Reimbursement Landscape
TABLE 33: U.S. IoT-Enabled Home Healthcare Devices Market: HIPAA, Data Privacy & Cybersecurity Landscape
TABLE 34: U.S. IoT-Enabled Home Healthcare Devices Market: Interoperability & EHR Integration Framework
TABLE 35: U.S. IoT-Enabled Home Healthcare Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 36: U.S. IoT-Enabled Home Healthcare Devices Market: Government Initiatives & Home-Based Care Programs
TABLE 37: U.S. IoT-Enabled Home Healthcare Devices Market: Product Category Snapshot, 2025
TABLE 38: Segment Dashboard; Definition and Scope, by Product Category
TABLE 39: U.S. IoT-Enabled Home Healthcare Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 40: U.S. IoT-Enabled Home Healthcare Devices Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 41: Connected Glucose Monitoring and Diabetes Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 42: Connected Vital-Sign and Multiparameter Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 43: Connected Cardiac Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 44: Connected Respiratory and Sleep Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 45: Smart Medication, Home Diagnostic, Safety and Other Connected Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: U.S. IoT-Enabled Home Healthcare Devices Market: Application Snapshot, 2025
TABLE 47: Segment Dashboard; Definition and Scope, by Application
TABLE 48: U.S. IoT-Enabled Home Healthcare Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 49: U.S. IoT-Enabled Home Healthcare Devices Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 50: Diabetes and Metabolic Disease Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: Cardiovascular and Hypertension Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: Respiratory and Sleep Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: Post-Acute and Transitional Care Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: Elderly Care, Multimorbidity and Preventive Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: U.S. IoT-Enabled Home Healthcare Devices Market: End User Snapshot, 2025
TABLE 56: Segment Dashboard; Definition and Scope, by End User
TABLE 57: U.S. IoT-Enabled Home Healthcare Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 58: U.S. IoT-Enabled Home Healthcare Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 59: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: Physician Practices and Specialty Clinics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: Home Healthcare and Post-Acute Care Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: Payers and Risk-Bearing Care Organizations Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: Patients, Caregivers and Consumer Health Channels Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: U.S. IoT-Enabled Home Healthcare Devices Market: Connectivity Technology Snapshot, 2025
TABLE 65: Segment Dashboard; Definition and Scope, by Connectivity Technology
TABLE 66: U.S. IoT-Enabled Home Healthcare Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 67: U.S. IoT-Enabled Home Healthcare Devices Market: Segment Share Analysis, by Connectivity Technology, 2025 & 2035 (%)
TABLE 68: Bluetooth and Smartphone-Connected Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: Wi-Fi and Home Network-Connected Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 70: Cellular-Enabled Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: NFC, Sensor-Based and Short-Range Connected Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: Hybrid and Multi-Connectivity Platforms Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: U.S. IoT-Enabled Home Healthcare Devices Market: Market Access & Reimbursement Snapshot
TABLE 74: CMS Remote Patient Monitoring Reimbursement Framework
TABLE 75: Medicare Advantage & Commercial Payer Connected-Care Landscape
TABLE 76: U.S. IoT-Enabled Home Healthcare Devices Market: Procurement Channel Analysis
TABLE 77: U.S. IoT-Enabled Home Healthcare Devices Market: Distribution Channel Analysis
TABLE 78: U.S. IoT-Enabled Home Healthcare Devices Market: Device-as-a-Service & Subscription Model Analysis
TABLE 79: U.S. IoT-Enabled Home Healthcare Devices Market: Patient Out-of-Pocket Economics
TABLE 80: U.S. IoT-Enabled Home Healthcare Devices Market: Procurement Decision Criteria Matrix
TABLE 81: U.S. IoT-Enabled Home Healthcare Devices Market: Regional Snapshot, 2025
TABLE 82: Segment Dashboard; Definition and Scope, by Geography
TABLE 83: U.S. IoT-Enabled Home Healthcare Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 84: U.S. IoT-Enabled Home Healthcare Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 85: West Region U.S. IoT-Enabled Home Healthcare Devices Market: Regional Overview & Trends
TABLE 86: West Region: Key Manufacturers and Connected-Care Ecosystem
TABLE 87: West Region Market, by State, 2021–2035 (US$ Billion)
TABLE 88: West Region Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 89: West Region Market, by Application, 2021–2035 (US$ Billion)
TABLE 90: California IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 91: Washington IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 92: Arizona IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 93: Colorado IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 94: Oregon IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 95: Utah IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 96: Nevada IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 97: New Mexico IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 98: Idaho IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 99: Montana IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 100: Wyoming IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 101: Alaska IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 102: Hawaii IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 103: Northeast Region U.S. IoT-Enabled Home Healthcare Devices Market: Regional Overview & Trends
TABLE 104: Northeast Region: Key Manufacturers and Connected-Care Ecosystem
TABLE 105: Northeast Region Market, by State, 2021–2035 (US$ Billion)
TABLE 106: Northeast Region Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 107: Northeast Region Market, by Application, 2021–2035 (US$ Billion)
TABLE 108: New York IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 109: Massachusetts IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 110: New Jersey IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 111: Pennsylvania IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 112: Connecticut IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 113: Maine IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 114: Vermont IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 115: New Hampshire IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 116: Rhode Island IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 117: Delaware IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 118: South Region U.S. IoT-Enabled Home Healthcare Devices Market: Regional Overview & Trends
TABLE 119: South Region: Key Manufacturers and Connected-Care Ecosystem
TABLE 120: South Region Market, by State, 2021–2035 (US$ Billion)
TABLE 121: South Region Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 122: South Region Market, by Application, 2021–2035 (US$ Billion)
TABLE 123: Texas IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 124: Florida IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 125: Georgia IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 126: North Carolina IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 127: Tennessee IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 128: South Carolina IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 129: Alabama IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 130: Mississippi IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 131: Louisiana IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 132: Arkansas IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 133: Kentucky IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 134: Oklahoma IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 135: Virginia IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 136: Maryland IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 137: West Virginia IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 138: Midwest Region U.S. IoT-Enabled Home Healthcare Devices Market: Regional Overview & Trends
TABLE 139: Midwest Region: Key Manufacturers and Connected-Care Ecosystem
TABLE 140: Midwest Region Market, by State, 2021–2035 (US$ Billion)
TABLE 141: Midwest Region Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 142: Midwest Region Market, by Application, 2021–2035 (US$ Billion)
TABLE 143: Illinois IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 144: Ohio IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 145: Michigan IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 146: Minnesota IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 147: Indiana IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 148: Wisconsin IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 149: Missouri IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 150: Iowa IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 151: Kansas IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 152: Nebraska IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 153: North Dakota IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 154: South Dakota IoT-Enabled Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 155: U.S. IoT-Enabled Home Healthcare Devices Market: Competitive Landscape Snapshot, 2025
TABLE 156: U.S. IoT-Enabled Home Healthcare Devices Market: Key Company Market Share Analysis, 2025
TABLE 157: U.S. IoT-Enabled Home Healthcare Devices Market: Company Positioning Matrix
TABLE 158: U.S. IoT-Enabled Home Healthcare Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 159: U.S. IoT-Enabled Home Healthcare Devices Market: Strategic Developments, Partnerships, M&A & Product Launches
TABLE 160: Abbott Laboratories: Company Profile
TABLE 161: Dexcom, Inc.: Company Profile
TABLE 162: Medtronic plc: Company Profile
TABLE 163: Insulet Corporation: Company Profile
TABLE 164: Tandem Diabetes Care, Inc.: Company Profile
TABLE 165: Omron Healthcare, Inc.: Company Profile
TABLE 166: Koninklijke Philips N.V.: Company Profile
TABLE 167: ResMed Inc.: Company Profile
TABLE 168: Masimo Corporation: Company Profile
TABLE 169: Baxter International Inc.: Company Profile
TABLE 170: GE HealthCare Technologies Inc.: Company Profile
TABLE 171: Roche Diabetes Care: Company Profile
TABLE 172: LifeScan, Inc.: Company Profile
TABLE 173: Ascensia Diabetes Care Holdings AG: Company Profile
TABLE 174: iRhythm Technologies, Inc.: Company Profile
TABLE 175: VitalConnect, Inc.: Company Profile
TABLE 176: BioIntelliSense, Inc.: Company Profile
TABLE 177: AliveCor, Inc.: Company Profile
TABLE 178: TytoCare Ltd.: Company Profile
TABLE 179: Withings Health Solutions: Company Profile
TABLE 180: Current Health / Best Buy Health: Company Profile
TABLE 181: ZOLL Medical Corporation: Company Profile
TABLE 182: Nonin Medical, Inc.: Company Profile
TABLE 183: A&D Medical: Company Profile
TABLE 184: Apple Inc.: Company Profile
TABLE 185: U.S. IoT-Enabled Home Healthcare Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 186: U.S. IoT-Enabled Home Healthcare Devices Market: Disruptive Technologies Impact Matrix
TABLE 187: U.S. IoT-Enabled Home Healthcare Devices Market: Emerging Business Trends
TABLE 188: U.S. IoT-Enabled Home Healthcare Devices Market: Business Opportunities for Startups & Existing Players
TABLE 189: U.S. IoT-Enabled Home Healthcare Devices Market: Investment Prioritization Matrix
TABLE 190: U.S. IoT-Enabled Home Healthcare Devices Market: Product Category Opportunity Matrix
TABLE 191: U.S. IoT-Enabled Home Healthcare Devices Market: State-Level Growth Opportunity Matrix
TABLE 192: U.S. IoT-Enabled Home Healthcare Devices Market: Technology Adoption Roadmap, 2026–2035
TABLE 193: U.S. IoT-Enabled Home Healthcare Devices Market: Strategic Recommendations for Medical Device Manufacturers
TABLE 194: U.S. IoT-Enabled Home Healthcare Devices Market: Strategic Recommendations for Hospitals & Health Systems
TABLE 195: U.S. IoT-Enabled Home Healthcare Devices Market: Strategic Recommendations for Home Healthcare Providers
TABLE 196: U.S. IoT-Enabled Home Healthcare Devices Market: Strategic Recommendations for Payers & Risk-Bearing Organizations
TABLE 197: U.S. IoT-Enabled Home Healthcare Devices Market: Strategic Recommendations for Investors & Private Equity Firms
TABLE 198: U.S. IoT-Enabled Home Healthcare Devices Market: Strategic Recommendations for Distributors & Channel Partners
TABLE 199: U.S. IoT-Enabled Home Healthcare Devices Market: Strategic Recommendations for New Entrants & Startups
TABLE 200: U.S. IoT-Enabled Home Healthcare Devices Market: Go-to-Market & Portfolio Expansion Guidance
TABLE 201: U.S. IoT-Enabled Home Healthcare Devices Market: Scope & Market Definition Limitation
TABLE 202: U.S. IoT-Enabled Home Healthcare Devices Market: Data Use Limitation
TABLE 203: U.S. IoT-Enabled Home Healthcare Devices Market: Forecasting Limitation
TABLE 204: U.S. IoT-Enabled Home Healthcare Devices Market: Regulatory & Reimbursement Disclaimer
TABLE 205: U.S. IoT-Enabled Home Healthcare Devices Market: Legal Disclaimer
TABLE 206: U.S. IoT-Enabled Home Healthcare Devices Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. IoT-Enabled Home Healthcare Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: U.S. IoT-Enabled Home Healthcare Devices Market Ecosystem
FIGURE 4: Stakeholder Ecosystem Analysis
FIGURE 5: Market Attractiveness Analysis
FIGURE 6: U.S. IoT-Enabled Home Healthcare Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 7: U.S. IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 8: U.S. IoT-Enabled Home Healthcare Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 9: U.S. IoT-Enabled Home Healthcare Devices Market Dynamics
FIGURE 10: Innovation & Patent Landscape, 2021–2025
FIGURE 11: Clinical Workflow Economics Framework
FIGURE 12: Home-Based Care Cost Economics Framework
FIGURE 13: Connected Device Procurement Decision Framework
FIGURE 14: Patient Onboarding & Engagement Economics Framework
FIGURE 15: Remote Monitoring Program ROI Framework
FIGURE 16: PESTEL Analysis
FIGURE 17: Porter’s Five Forces Analysis
FIGURE 18: Value Chain Analysis
FIGURE 19: Supply Chain Analysis
FIGURE 20: Connected Device Data & Cloud Infrastructure Ecosystem
FIGURE 21: FDA Regulatory Framework for Connected Home-Use Medical Devices
FIGURE 22: CMS Remote Patient Monitoring Reimbursement Framework
FIGURE 23: Cybersecurity, Data Privacy & Interoperability Framework
FIGURE 24: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 25: Product Category Segment Market Size Forecast & Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Connected Glucose Monitoring and Diabetes Devices Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 27: Connected Vital-Sign and Multiparameter Monitoring Devices Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 28: Connected Cardiac Monitoring Devices Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 29: Connected Respiratory and Sleep Devices Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 30: Smart Medication, Home Diagnostic, Safety and Other Connected Devices Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 31: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 32: Application Segment Market Size Forecast & Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Diabetes and Metabolic Disease Management Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 34: Cardiovascular and Hypertension Management Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 35: Respiratory and Sleep Management Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 36: Post-Acute and Transitional Care Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 37: Elderly Care, Multimorbidity and Preventive Monitoring Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 38: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 39: End User Segment Market Size Forecast & Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Hospitals and Integrated Health Systems Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 41: Physician Practices and Specialty Clinics Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 42: Home Healthcare and Post-Acute Care Providers Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 43: Payers and Risk-Bearing Care Organizations Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 44: Patients, Caregivers and Consumer Health Channels Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 45: Connectivity Technology Segment Market Share Analysis, 2025 & 2035
FIGURE 46: Connectivity Technology Segment Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 47: Bluetooth and Smartphone-Connected Devices Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 48: Wi-Fi and Home Network-Connected Devices Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 49: Cellular-Enabled Devices Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 50: NFC, Sensor-Based and Short-Range Connected Technologies Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 51: Hybrid and Multi-Connectivity Platforms Market Size Forecast & Trend Analysis, 2021–2035
FIGURE 52: CMS RPM & Connected-Care Market Access Framework
FIGURE 53: U.S. IoT-Enabled Home Healthcare Device Procurement Framework
FIGURE 54: Distribution & Commercial Channel Ecosystem
FIGURE 55: Device-as-a-Service and Recurring Revenue Model Framework
FIGURE 56: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 57: Regional Segment Market Size Forecast & Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: West Region Market Share & Connected-Care Ecosystem, 2025
FIGURE 59: West Region Market Share Analysis by State, 2025
FIGURE 60: West Region Market Size Forecast & Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: California IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 62: Washington IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 63: Arizona IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 64: Colorado IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 65: Oregon IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 66: Utah IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 67: Nevada IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 68: New Mexico IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 69: Idaho IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 70: Montana IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 71: Wyoming IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 72: Alaska IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 73: Hawaii IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 74: Northeast Region Market Share & Connected-Care Ecosystem, 2025
FIGURE 75: Northeast Region Market Share Analysis by State, 2025
FIGURE 76: Northeast Region Market Size Forecast & Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: New York IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 78: Massachusetts IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 79: New Jersey IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 80: Pennsylvania IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 81: Connecticut IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 82: Maine IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 83: Vermont IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 84: New Hampshire IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 85: Rhode Island IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 86: Delaware IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 87: South Region Market Share & Connected-Care Ecosystem, 2025
FIGURE 88: South Region Market Share Analysis by State, 2025
FIGURE 89: South Region Market Size Forecast & Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Texas IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 91: Florida IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 92: Georgia IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 93: North Carolina IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 94: Tennessee IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 95: South Carolina IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 96: Alabama IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 97: Mississippi IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 98: Louisiana IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 99: Arkansas IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 100: Kentucky IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 101: Oklahoma IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 102: Virginia IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 103: Maryland IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 104: West Virginia IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 105: Midwest Region Market Share & Connected-Care Ecosystem, 2025
FIGURE 106: Midwest Region Market Share Analysis by State, 2025
FIGURE 107: Midwest Region Market Size Forecast & Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Illinois IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 109: Ohio IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 110: Michigan IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 111: Minnesota IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 112: Indiana IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 113: Wisconsin IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 114: Missouri IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 115: Iowa IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 116: Kansas IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 117: Nebraska IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 118: North Dakota IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 119: South Dakota IoT-Enabled Home Healthcare Devices Market Size, Forecast & Trend Analysis, 2021–2035
FIGURE 120: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 121: Company Positioning Matrix
FIGURE 122: Key Player Product Portfolio Benchmarking
FIGURE 123: Strategic Developments, Partnerships, M&A & Product Launches
FIGURE 124: U.S. IoT-Enabled Home Healthcare Devices Innovation Roadmap
FIGURE 125: Continuous Biosensing & Wearable Sensor Adoption Roadmap
FIGURE 126: AI-Assisted Remote Patient Monitoring Opportunity Map
FIGURE 127: Cellular-Enabled Home Monitoring Growth Roadmap
FIGURE 128: Connected Home Diagnostics Technology Opportunity Map
FIGURE 129: Future Market Scenario Analysis, 2026–2035
FIGURE 130: Disruptive Technologies Impact Matrix
FIGURE 131: Emerging Business Trends Matrix
FIGURE 132: Investment Prioritization Matrix
FIGURE 133: Product Category Opportunity Matrix
FIGURE 134: State-Level Growth Opportunity Map
FIGURE 135: Technology Adoption Roadmap, 2026–2035
FIGURE 136: Strategic Growth Roadmap for U.S. IoT-Enabled Home Healthcare Device Companies
FIGURE 137: Go-to-Market Strategy Framework
FIGURE 138: FDA, Reimbursement & Market Access Strategy Framework
FIGURE 139: Product Positioning & Portfolio Expansion Framework
FIGURE 140: Connected-Care Partnership & Ecosystem Strategy Framework
FIGURE 141: Report Scope, Limitations & Disclaimer Framework